- Home
- AIRI vs TOI Comparison
AIRI vs TOI Comparison
Compare AIRI & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- TOI
- Stock Information
- Founded
- AIRI 1979
- TOI 2007
- Country
- AIRI United States
- TOI United States
- Employees
- AIRI N/A
- TOI N/A
- Industry
- AIRI Military/Government/Technical
- TOI Medical/Nursing Services
- Sector
- AIRI Industrials
- TOI Health Care
- Exchange
- AIRI Nasdaq
- TOI Nasdaq
- Market Cap
- AIRI 20.2M
- TOI 20.1M
- IPO Year
- AIRI N/A
- TOI N/A
- Fundamental
- Price
- AIRI $4.60
- TOI $0.18
- Analyst Decision
- AIRI
- TOI Strong Buy
- Analyst Count
- AIRI 0
- TOI 1
- Target Price
- AIRI N/A
- TOI $2.50
- AVG Volume (30 Days)
- AIRI 67.0K
- TOI 297.4K
- Earning Date
- AIRI 11-14-2024
- TOI 11-13-2024
- Dividend Yield
- AIRI N/A
- TOI N/A
- EPS Growth
- AIRI N/A
- TOI N/A
- EPS
- AIRI N/A
- TOI N/A
- Revenue
- AIRI $53,657,000.00
- TOI $378,933,000.00
- Revenue This Year
- AIRI $9.26
- TOI $29.17
- Revenue Next Year
- AIRI $8.73
- TOI $16.43
- P/E Ratio
- AIRI N/A
- TOI N/A
- Revenue Growth
- AIRI 3.31
- TOI 22.29
- 52 Week Low
- AIRI $2.89
- TOI $0.18
- 52 Week High
- AIRI $9.44
- TOI $2.50
- Technical
- Relative Strength Index (RSI)
- AIRI 32.15
- TOI 24.09
- Support Level
- AIRI $5.63
- TOI $0.25
- Resistance Level
- AIRI $6.18
- TOI $0.30
- Average True Range (ATR)
- AIRI 0.36
- TOI 0.04
- MACD
- AIRI -0.13
- TOI -0.01
- Stochastic Oscillator
- AIRI 6.15
- TOI -0.06
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.